Retour

AIM ImmunoTech to Discuss First Quarter 2024 Financial Results on May 16, 2024, and Host Conference Call and Webcast

Calendar Calendar of Events

OCALA, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) announced today that management will host a conference call and webcast to discuss the Company’s Q1 2024 operational and financial results on Thursday, May 16, 2024, at 8:30 AM ET.

GlobeNewswire Inc. • 09/05/2024 à 14:50:00
AIM ImmunoTech Inc.
Address: 2117 SW HIGHWAY 484
Postal Code: 32801
City: OCALA
State: FL
Phone Number: 352-448-7797
Website: https://www.aimimmuno.com
Status: Active
Company Info

AIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics to treat immune disorders and viral and cancer diseases. AIM's flagship products include Ampligen (Rintatolimod), a drug of large macromolecular RNA molecules for cancer and viral diseases, and the drug Alferon N Injection for a category of STD infection. Clinical trials of Ampligen include studies of cancer patients with renal cell carcinoma, malignant melanoma, colorectal cancer, advanced recurrent ovarian cancer, and triple-negative metastatic breast cancer. It is also advancing Ampligen as a potential treatment for COVID-19. FDA has authorized the first human trial assessing the safety and effectiveness of Ampligen in combination with interferon alfa-2b, in cancer patients with COVID-19.

List Date1995-11-02
MarketStocks
LocalUS
Primary ExchangeXASE
TypeCS
Currency NameUSD
CIK0000946644
Composite figiBBG000JL6Z80
Share Class figiBBG001SB9J29
Market Cap20,507,998 USD
SIC Code2836
SIC DescriptionBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Total Employees28
Share Class Shares Outstanding51280000
Weighted Shares Outstanding50888333
Round Lot100
Updated date2024-05-19
Stats
Last 5 days
17-05
16-05
15-05
14-05
13-05
Last
0.395
0.419
0.397
0.395
0.42
Variance
-5.28%
5.54%
3.12%
-5.95%
3.7%
Open
0.417
0.397
0.385
0.42
0.405
Highest
0.424
0.419
0.405
0.429
0.425
Lowest
0.424
0.415
0.405
0.426
0.425
History
PeriodVarhighestlowest
1 week
-2.47%
0.425
0.405
1 month
-15.96%
0.495
0.405
3 month
1.54%
0.425
0.367
6 month
-9.3%
0.44
0.367
1 year
-17.71%
0.499899
0.367
3 year
-80.64%
2.105
0.291
5 year
-73.84%
2
0.291
10 year
-73.84%
2
0.291
Stock Financials
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-15 2023-08-14 2023-11-14 UNPUB
Assets 37,462,000 33,617,000 27,861,000 UNPUB
Current Assets 33,160,000 28,869,000 22,742,000 UNPUB
Current Liabilities 1,837,000 2,885,000 4,716,000 UNPUB
Equity 34,989,000 30,135,000 22,602,000 UNPUB
Equity Attributable To Noncontrolling Interest 0 0 0 UNPUB
Equity Attributable To Parent 34,989,000 30,135,000 22,602,000 UNPUB
Liabilities 2,473,000 3,482,000 5,259,000 UNPUB
Liabilities And Equity 37,462,000 33,617,000 27,861,000 UNPUB
Noncurrent Assets 4,302,000 4,748,000 5,119,000 UNPUB
Noncurrent Liabilities 636,000 597,000 543,000 UNPUB
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-15 2023-08-14 2023-11-14 UNPUB
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 0 -6,015,000 -5,774,000 UNPUB
Net Cash Flow, Continuing 0 -6,015,000 -5,774,000 UNPUB
Net Cash Flow From Financing Activities 3,758,000 -3,653,000 233,000 UNPUB
Net Cash Flow From Financing Activities, Continuing 3,758,000 -3,653,000 233,000 UNPUB
Net Cash Flow From Investing Activities -78,000 -204,000 -336,000 UNPUB
Net Cash Flow From Investing Activities, Continuing -78,000 -204,000 -336,000 UNPUB
Net Cash Flow From Operating Activities -3,680,000 -2,158,000 -5,671,000 UNPUB
Net Cash Flow From Operating Activities, Continuing -3,680,000 -2,158,000 -5,671,000 UNPUB
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-15 2023-08-14 2023-11-14 UNPUB
Comprehensive Income/Loss -3,661,000 -4,909,000 -7,816,000 UNPUB
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Comprehensive Income/Loss Attributable To Parent -3,661,000 -4,909,000 -7,816,000 UNPUB
Other Comprehensive Income/Loss -3,661,000 -4,909,000 -7,816,000 UNPUB
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-15 2023-08-14 2023-11-14 UNPUB
Basic Earnings Per Share 0 0 0 UNPUB
Benefits Costs and Expenses 4,344,000 5,503,000 8,203,000 UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 4,344,000 5,503,000 8,203,000 UNPUB
Diluted Earnings Per Share UNPUB 0 0 UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -3,661,000 -4,909,000 -7,816,000 UNPUB
Income/Loss From Continuing Operations Before Tax -4,295,000 -5,461,000 -8,157,000 UNPUB
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -3,661,000 -4,909,000 -7,816,000 UNPUB
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Net Income/Loss Attributable To Parent -3,661,000 -4,909,000 -7,816,000 UNPUB
Net Income/Loss Available To Common Stockholders, Basic -3,661,000 -4,909,000 -7,816,000 UNPUB
Operating Expenses 4,344,000 5,503,000 8,203,000 UNPUB
Operating Income/Loss -4,295,000 -5,461,000 -8,157,000 UNPUB
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 UNPUB
Preferred Stock Dividends And Other Adjustments 0 0 0 UNPUB
Revenues 49,000 42,000 46,000 UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-13 2022-08-15 2022-11-14 2023-03-31
Assets 54,155,000 50,884,000 46,285,000 40,488,000
Current Assets 50,380,000 46,045,000 41,150,000 36,321,000
Current Liabilities 766,000 1,368,000 2,895,000 1,361,000
Equity 53,301,000 48,780,000 42,695,000 38,468,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 53,301,000 48,780,000 42,695,000 38,468,000
Liabilities -53,301,000 -48,780,000 3,590,000 2,020,000
Liabilities And Equity 54,155,000 50,884,000 46,285,000 40,488,000
Noncurrent Assets 3,775,000 4,839,000 5,135,000 4,167,000
Noncurrent Liabilities 0 0 695,000 659,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-13 2022-08-15 2022-11-14 2023-03-31
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 0 2,359,000 -4,693,000 -5,040,000
Net Cash Flow, Continuing 0 2,359,000 -4,693,000 -5,040,000
Net Cash Flow From Financing Activities 3,104,000 -3,049,000 25,000 80,000
Net Cash Flow From Financing Activities, Continuing 3,104,000 -3,049,000 25,000 80,000
Net Cash Flow From Investing Activities -346,000 7,721,000 250,000 10,988,000
Net Cash Flow From Investing Activities, Continuing -346,000 7,721,000 250,000 10,988,000
Net Cash Flow From Operating Activities -2,758,000 -2,313,000 -4,968,000 -16,108,000
Net Cash Flow From Operating Activities, Continuing -2,758,000 -2,313,000 -4,968,000 -16,108,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-13 2022-08-15 2022-11-14 2023-03-31
Comprehensive Income/Loss -3,820,000 -4,851,000 -6,385,000 -19,445,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -3,820,000 -4,851,000 -6,385,000 -19,445,000
Other Comprehensive Income/Loss -3,820,000 -4,851,000 -6,385,000 -19,445,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-13 2022-08-15 2022-11-14 2023-03-31
Basic Earnings Per Share 0 0 0 0
Benefits Costs and Expenses 3,185,000 4,725,000 6,542,000 20,064,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 3,185,000 4,725,000 6,542,000 20,064,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -3,820,000 -4,851,000 -6,385,000 -19,445,000
Income/Loss From Continuing Operations Before Tax -3,152,000 -4,695,000 -6,521,000 -19,923,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -3,820,000 -4,851,000 -6,385,000 -19,445,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -3,820,000 -4,851,000 -6,385,000 -19,445,000
Net Income/Loss Available To Common Stockholders, Basic -3,820,000 -4,851,000 -6,385,000 -19,445,000
Operating Expenses 3,185,000 4,725,000 6,542,000 20,064,000
Operating Income/Loss -3,152,000 -4,695,000 -6,521,000 -19,923,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 33,000 30,000 21,000 141,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-17 2021-08-16 2021-11-15 2022-03-31
Assets 74,089,000 66,722,000 63,080,000 57,699,000
Current Assets 51,219,000 41,325,000 38,037,000 50,213,000
Current Liabilities 970,000 876,000 767,000 673,000
Equity 70,965,000 65,532,000 62,047,000 56,879,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 70,965,000 65,532,000 62,047,000 56,879,000
Liabilities -70,965,000 -65,532,000 1,033,000 820,000
Liabilities And Equity 74,089,000 66,722,000 63,080,000 57,699,000
Noncurrent Assets 22,870,000 25,397,000 25,043,000 7,486,000
Noncurrent Liabilities 0 0 266,000 147,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-17 2021-08-16 2021-11-15 2022-03-31
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 10,272,000 -7,631,000 -3,793,000 -6,408,000
Net Cash Flow, Continuing 10,272,000 -7,631,000 -3,793,000 -6,408,000
Net Cash Flow From Financing Activities 12,794,000 -4,761,000 30,000 8,188,000
Net Cash Flow From Financing Activities, Continuing 12,794,000 -4,761,000 30,000 8,188,000
Net Cash Flow From Investing Activities 523,000 -1,152,000 -366,000 -631,000
Net Cash Flow From Investing Activities, Continuing 523,000 -1,152,000 -366,000 -631,000
Net Cash Flow From Operating Activities -3,045,000 -1,718,000 -3,457,000 -13,965,000
Net Cash Flow From Operating Activities, Continuing -3,045,000 -1,718,000 -3,457,000 -13,965,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-17 2021-08-16 2021-11-15 2022-03-31
Comprehensive Income/Loss -3,742,000 -5,913,000 -3,829,000 -19,080,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -3,742,000 -5,913,000 -3,829,000 -19,080,000
Other Comprehensive Income/Loss -3,742,000 -5,913,000 -3,829,000 -19,080,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-17 2021-08-16 2021-11-15 2022-03-31
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 3,773,000 3,741,000 -3,962,000 18,973,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 3,773,000 3,741,000 -3,962,000 18,973,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -3,579,000 -5,876,000 -3,826,000 -19,127,000
Income/Loss From Continuing Operations Before Tax -3,745,000 -3,718,000 3,995,000 -18,838,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating 50,000 19,000 UNPUB 67,000
Net Income/Loss -3,579,000 -5,876,000 -3,826,000 -19,127,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -3,579,000 -5,876,000 -3,826,000 -19,127,000
Net Income/Loss Available To Common Stockholders, Basic -3,579,000 -5,876,000 -3,826,000 -19,127,000
Operating Expenses 3,773,000 3,741,000 3,962,000 18,973,000
Operating Income/Loss -3,745,000 -3,718,000 -3,929,000 -18,838,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 28,000 23,000 33,000 135,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-14 2020-08-14 2020-11-12 2021-03-31
Assets 42,407,000 50,123,000 64,164,000 64,584,000
Current Assets 29,710,000 35,165,000 39,757,000 40,310,000
Current Liabilities 703,000 833,000 795,000 1,102,000
Equity 35,111,000 46,992,000 61,112,000 61,294,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 35,111,000 46,992,000 61,112,000 61,294,000
Liabilities 7,296,000 3,131,000 3,052,000 3,290,000
Liabilities And Equity 42,407,000 50,123,000 64,164,000 64,584,000
Noncurrent Assets 12,697,000 14,958,000 24,407,000 24,274,000
Noncurrent Liabilities 6,593,000 2,298,000 2,257,000 2,188,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-14 2020-08-14 2020-11-12 2021-03-31
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 26,120,000 6,318,000 4,588,000 37,031,000
Net Cash Flow, Continuing 26,120,000 6,318,000 4,588,000 37,031,000
Net Cash Flow From Financing Activities 25,687,000 10,675,000 17,160,000 56,563,000
Net Cash Flow From Financing Activities, Continuing 25,687,000 10,675,000 17,160,000 56,563,000
Net Cash Flow From Investing Activities 3,493,000 -2,892,000 -9,583,000 -9,164,000
Net Cash Flow From Investing Activities, Continuing 3,493,000 -2,892,000 -9,583,000 -9,164,000
Net Cash Flow From Operating Activities -3,060,000 -1,465,000 -2,989,000 -10,368,000
Net Cash Flow From Operating Activities, Continuing -3,060,000 -1,465,000 -2,989,000 -10,368,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-14 2020-08-14 2020-11-12 2021-03-31
Comprehensive Income/Loss -3,812,000 -3,303,000 -3,381,000 -14,447,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -3,812,000 -3,303,000 -3,381,000 -14,447,000
Other Comprehensive Income/Loss -3,812,000 -3,303,000 -3,381,000 -14,447,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-14 2020-08-14 2020-11-12 2021-03-31
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 3,370,000 3,380,000 3,391,000 15,315,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 3,370,000 3,380,000 3,391,000 15,315,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -3,808,000 -3,370,000 -3,306,000 -14,400,000
Income/Loss From Continuing Operations Before Tax -3,325,000 -3,340,000 -3,355,000 -15,152,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB 672,000
Net Income/Loss -3,808,000 -3,370,000 -3,306,000 -14,400,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -3,808,000 -3,370,000 -3,306,000 -14,400,000
Net Income/Loss Available To Common Stockholders, Basic -3,808,000 -3,370,000 -3,306,000 -14,400,000
Operating Expenses 3,370,000 3,380,000 3,391,000 15,315,000
Operating Income/Loss -3,325,000 -3,340,000 -3,355,000 -15,152,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 45,000 40,000 36,000 163,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB 2019-11-14 2020-03-30
Assets UNPUB UNPUB 22,490,000 20,219,000
Current Assets UNPUB UNPUB 12,621,000 10,446,000
Current Liabilities UNPUB UNPUB 4,191,000 1,127,000
Equity UNPUB UNPUB 13,844,000 12,907,000
Equity Attributable To Noncontrolling Interest UNPUB UNPUB 0 0
Equity Attributable To Parent UNPUB UNPUB 13,844,000 12,907,000
Liabilities UNPUB UNPUB 8,646,000 7,312,000
Liabilities And Equity UNPUB UNPUB 22,490,000 20,219,000
Noncurrent Assets UNPUB UNPUB 9,869,000 9,773,000
Noncurrent Liabilities UNPUB UNPUB 4,455,000 6,185,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB 2019-11-14 2020-03-30
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow UNPUB UNPUB 8,657,000 1,171,000
Net Cash Flow, Continuing UNPUB UNPUB 8,657,000 1,171,000
Net Cash Flow From Financing Activities UNPUB UNPUB 11,433,000 16,385,000
Net Cash Flow From Financing Activities, Continuing UNPUB UNPUB 11,433,000 16,385,000
Net Cash Flow From Investing Activities UNPUB UNPUB -232,000 -6,147,000
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB -232,000 -6,147,000
Net Cash Flow From Operating Activities UNPUB UNPUB -2,544,000 -9,067,000
Net Cash Flow From Operating Activities, Continuing UNPUB UNPUB -2,544,000 -9,067,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB 2019-11-14 2020-03-30
Comprehensive Income/Loss UNPUB UNPUB -2,948,000 -9,533,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB 0 0
Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB -2,948,000 -9,533,000
Other Comprehensive Income/Loss UNPUB UNPUB -2,948,000 -9,533,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB 2019-11-14 2020-03-30
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB 3,266,000 12,583,000
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB 3,266,000 12,583,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax UNPUB UNPUB -2,948,000 -9,533,000
Income/Loss From Continuing Operations Before Tax UNPUB UNPUB -3,205,000 -12,443,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB 43,781 UNPUB
Net Income/Loss UNPUB UNPUB -2,948,000 -9,533,000
Net Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB 0 0
Net Income/Loss Attributable To Parent UNPUB UNPUB -2,948,000 -9,533,000
Net Income/Loss Available To Common Stockholders, Basic UNPUB UNPUB -2,948,000 -9,533,000
Operating Expenses UNPUB UNPUB 3,266,000 12,583,000
Operating Income/Loss UNPUB UNPUB -3,205,000 -12,443,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic UNPUB UNPUB 0 0
Preferred Stock Dividends And Other Adjustments UNPUB UNPUB 0 0
Revenues UNPUB UNPUB 61,000 140,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2013-06-13 UNPUB UNPUB UNPUB
Assets 22,114,000 UNPUB UNPUB UNPUB
Current Assets 14,436,000 UNPUB UNPUB UNPUB
Current Liabilities 6,876,000 UNPUB UNPUB UNPUB
Equity 11,715,000 UNPUB UNPUB UNPUB
Equity Attributable To Noncontrolling Interest 0 UNPUB UNPUB UNPUB
Equity Attributable To Parent 11,715,000 UNPUB UNPUB UNPUB
Liabilities 10,399,000 UNPUB UNPUB UNPUB
Liabilities And Equity 22,114,000 UNPUB UNPUB UNPUB
Noncurrent Assets 7,678,000 UNPUB UNPUB UNPUB
Noncurrent Liabilities 3,523,000 UNPUB UNPUB UNPUB
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2013-06-13 UNPUB UNPUB UNPUB
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 0 UNPUB UNPUB UNPUB
Net Cash Flow, Continuing 0 UNPUB UNPUB UNPUB
Net Cash Flow From Financing Activities -772,000 UNPUB UNPUB UNPUB
Net Cash Flow From Financing Activities, Continuing -772,000 UNPUB UNPUB UNPUB
Net Cash Flow From Investing Activities -202,000 UNPUB UNPUB UNPUB
Net Cash Flow From Investing Activities, Continuing -202,000 UNPUB UNPUB UNPUB
Net Cash Flow From Operating Activities 974,000 UNPUB UNPUB UNPUB
Net Cash Flow From Operating Activities, Continuing 974,000 UNPUB UNPUB UNPUB
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2013-06-13 UNPUB UNPUB UNPUB
Comprehensive Income/Loss -413,000 UNPUB UNPUB UNPUB
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 UNPUB UNPUB UNPUB
Comprehensive Income/Loss Attributable To Parent -413,000 UNPUB UNPUB UNPUB
Other Comprehensive Income/Loss 0 UNPUB UNPUB UNPUB
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2013-06-13 UNPUB UNPUB UNPUB
Basic Earnings Per Share 0 UNPUB UNPUB UNPUB
Benefits Costs and Expenses 7,764,000 UNPUB UNPUB UNPUB
Cost Of Revenue 4,643,000 UNPUB UNPUB UNPUB
Costs And Expenses 7,764,000 UNPUB UNPUB UNPUB
Diluted Earnings Per Share 0 UNPUB UNPUB UNPUB
Gross Profit 2,465,000 UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -413,000 UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations Before Tax -656,000 UNPUB UNPUB UNPUB
Income Tax Expense/Benefit -243,000 UNPUB UNPUB UNPUB
Interest Expense, Operating 31,000 UNPUB UNPUB UNPUB
Net Income/Loss -413,000 UNPUB UNPUB UNPUB
Net Income/Loss Attributable To Noncontrolling Interest 0 UNPUB UNPUB UNPUB
Net Income/Loss Attributable To Parent -413,000 UNPUB UNPUB UNPUB
Net Income/Loss Available To Common Stockholders, Basic -413,000 UNPUB UNPUB UNPUB
Operating Expenses 3,094,000 UNPUB UNPUB UNPUB
Operating Income/Loss -629,000 UNPUB UNPUB UNPUB
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 UNPUB UNPUB UNPUB
Preferred Stock Dividends And Other Adjustments 0 UNPUB UNPUB UNPUB
Revenues 7,108,000 UNPUB UNPUB UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2013-05-01
Assets UNPUB UNPUB UNPUB 23,324,000
Current Assets UNPUB UNPUB UNPUB 15,730,000
Current Liabilities UNPUB UNPUB UNPUB 6,646,000
Equity UNPUB UNPUB UNPUB 12,040,000
Equity Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Equity Attributable To Parent UNPUB UNPUB UNPUB 12,040,000
Liabilities UNPUB UNPUB UNPUB 11,284,000
Liabilities And Equity UNPUB UNPUB UNPUB 23,324,000
Noncurrent Assets UNPUB UNPUB UNPUB 7,594,000
Noncurrent Liabilities UNPUB UNPUB UNPUB 4,638,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2013-05-01
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow UNPUB UNPUB UNPUB -157,000
Net Cash Flow, Continuing UNPUB UNPUB UNPUB -157,000
Net Cash Flow From Financing Activities UNPUB UNPUB UNPUB -2,966,000
Net Cash Flow From Financing Activities, Continuing UNPUB UNPUB UNPUB -2,966,000
Net Cash Flow From Investing Activities UNPUB UNPUB UNPUB 615,000
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB UNPUB 615,000
Net Cash Flow From Operating Activities UNPUB UNPUB UNPUB 2,194,000
Net Cash Flow From Operating Activities, Continuing UNPUB UNPUB UNPUB 2,194,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2013-05-01
Comprehensive Income/Loss UNPUB UNPUB UNPUB 2,522,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB 2,522,000
Other Comprehensive Income/Loss UNPUB UNPUB UNPUB 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2013-05-01
Basic Earnings Per Share UNPUB UNPUB UNPUB 1
Benefits Costs and Expenses UNPUB UNPUB UNPUB 27,579,000
Cost Of Revenue UNPUB UNPUB UNPUB 19,091,000
Costs And Expenses UNPUB UNPUB UNPUB 27,579,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB 1
Gross Profit UNPUB UNPUB UNPUB 11,930,000
Income/Loss From Continuing Operations After Tax UNPUB UNPUB UNPUB 2,522,000
Income/Loss From Continuing Operations Before Tax UNPUB UNPUB UNPUB 3,442,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 920,000
Interest Expense, Operating UNPUB UNPUB UNPUB 258,000
Net Income/Loss UNPUB UNPUB UNPUB 2,522,000
Net Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Net Income/Loss Attributable To Parent UNPUB UNPUB UNPUB 2,522,000
Net Income/Loss Available To Common Stockholders, Basic UNPUB UNPUB UNPUB 2,522,000
Operating Expenses UNPUB UNPUB UNPUB 10,139,000
Operating Income/Loss UNPUB UNPUB UNPUB 1,791,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic UNPUB UNPUB UNPUB 0
Preferred Stock Dividends And Other Adjustments UNPUB UNPUB UNPUB 0
Revenues UNPUB UNPUB UNPUB 31,021,000
Calendar
20 May 2024 (Time UTC) Actual Previous Consensus
★★
09:00
United States
19 May 2024 (Time UTC) Actual Previous Consensus
★★★
15:30
United States
17 May 2024 (Time UTC) Actual Previous Consensus
★
15:30
United States
-5400.000
-17800.000
★
15:30
United States
-66000.000
-60000.000
★
15:30
United States
59500.000
53700.000
★
15:30
United States
-116600.000
-135800.000
★★
15:30
United States
3200.000
4400.000
★
15:30
United States
203000.000
215400.000
★
15:30
United States
200.000
-31400.000
★
15:30
United States
61800.000
62600.000
★
15:30
United States
1300.000
1300.000
★
15:30
United States
-25300.000
-9700.000
★
15:30
United States
204500.000
199600.000
★★
15:30
United States
★
15:30
United States
News Stream
Calendar Calendar of Events
AIM ImmunoTech Reports First Quarter 2024 Financial Results and Provides Corporate Update
Continued execution across Ampligen® clinical development programs and growing body of positive data in multiple high-value indications
GlobeNewswire Inc. • 3d ago
Calendar Calendar of Events
AIM ImmunoTech to Discuss First Quarter 2024 Financial Results on May 16, 2024, and Host Conference Call and Webcast
OCALA, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) announced today that management will host a conference call and webcast to discuss the Company’s Q1 2024 operational and financial results on Thursday, May 16, 2024, at 8:30 AM ET.
GlobeNewswire Inc. • 1w ago
News Clinical Study
AIM ImmunoTech Announces First Dose Level is Generally Well-Tolerated in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer
Next safety cohort to begin escalated dosing soon Next safety cohort to begin escalated dosing soon
GlobeNewswire Inc. • 2w ago
Management Directors and Officers
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
OCALA, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced the next CEO Corner segment has been published on the Company’s website. For the CEO Corner segment, Thomas Equels, Chief Executive Officer of AIM ImmunoTech, gave an overview of Metastatic Pancreatic Cancer and the ongoing Phase 1b/2 clinical trial combining AIM’s Ampligen® (rintatolimod) with AstraZeneca’s anti-PD-L1 immune checkpoint inhibitor Imfinzi® (durvalumab) for the treatment of late-stage pancreatic cancer (the “DURIPANC Study”).
GlobeNewswire Inc. • 3w ago
Stocks Company Announcement
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
OCALA, Fla., April 18, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced the next CEO Corner segment has been published on the Company’s website. For the CEO Corner segment, Thomas Equels, Chief Executive Officer of AIM ImmunoTech, gave an overview of Locally Advanced Pancreatic Adenocarcinoma and the unmet need.
GlobeNewswire Inc. • 1mo ago
Management Directors and Officers
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
OCALA, Fla., April 11, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced the next CEO Corner segment has been published on the Company’s website. For the CEO Corner segment, Thomas Equels, Chief Executive Officer of AIM ImmunoTech, discussed the Company’s recent news release regarding top-line interim data indicating that combining Ampligen (rintatolimod) with Keytruda (pembrolizumab) in the treatment of recurrent ovarian cancer may have a powerful synergistic effect that could be far more effective than pembrolizumab alone as a therapy for the disease.
GlobeNewswire Inc. • 1mo ago
Health Health
AIM ImmunoTech 宣布 Ampligen 与 Pembrolizumab 联合用药治疗复发性卵巢癌的研究取得积极顶线、方案计划中期报告数据
佛罗里达州奥卡拉, April 11, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM)（以下简称“AIM”）今日宣布了顶线中期数据，表明 Ampligen (rintatolimod) 和 Keytruda (pembrolizumab) 的联合用药在治疗复发性卵巢癌方面可能具有强大的协同作用。研究者由此得出结论，认为与单独使用 pembrolizumab 相比，该联合疗法对于治疗该疾病可能有效得多。
GlobeNewswire Inc. • 1mo ago
Health Health
AIM ImmunoTech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer
OCALA, Fla., April 10, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM”) today announced top-line interim data indicating that combining Ampligen (rintatolimod) with Keytruda (pembrolizumab) in the treatment of recurrent ovarian cancer may have a powerful synergistic effect, leading the investigator to conclude that the combination therapy could be far more effective than pembrolizumab alone as a therapy for the disease.
GlobeNewswire Inc. • 1mo ago
Calendar Calendar of Events
AIM ImmunoTech Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Year marked by growing body of promising data demonstrating Ampligen’s potential to address multiple high-value indications
GlobeNewswire Inc. • 1mo ago
Calendar Calendar of Events
AIM ImmunoTech to Present at the MedInvest Biotech & Pharma Investor Conference
Live webcast presentation on Wednesday, April 3rd at 1:35 PM ET Live webcast presentation on Wednesday, April 3rd at 1:35 PM ET
GlobeNewswire Inc. • 1mo ago
See All
Related
Latest

Contactez-nous dès aujourd'hui pour découvrir comment notre solution peut vous aider à tirer parti de la puissance des données.

CONTACTER UN EXPERT